Zdrowie i gospodarka · 31/05/2018
FDA Requests Public Comment on Proposed Clinical Trial Data Monitoring Committee Guidance
The Food and Drug Administration is seeking public input on a proposed rule regarding the establishment and operation of clinical trial data monitoring committees, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →